Headache & Pain

Filter Your Results

 

News

 

News

March/April 2018—Lawful Physician-Hastened Death, Hearing Loss and Cognitive Impairment, Extended-Release Amantadine, Fibromyalgia Biomarkers, Phase 3 Trial of Rimegepant for Migraine, A Blood Test for Concussion, and more.

Biomarkers Available to Speed Diagnosis of Fibromyalgia

Wednesday, March 07, 2018—Iquity (Nashville, Tennessee) has announced the release of IsolateFibromyalgia, an RNA analysis of blood samples, for the fast and accurate detection of fibromyalgia syndrome.…

First Patient Enrolled in Phase 3 Clinical Trial of Rimegepant for Acute Migraine Treatment

Tuesday, March 06, 2018—Biohaven Pharmaceutical (New Haven, CT) announced today the first patient enrollment in their phase 3 clinical trial of rimegepant (Zydis) for the acute treatment of migraine.…

Biosimilar Being Developed for Botox

Thursday, March 01, 2018—In a transatlantic collaboration, Mylan N.V. (Pittsburgh, Pennsylvania) and Revance Therapeutics, Inc. (Hertsfordshire, England) have reached an agreement to collaborate on th…

Migraine Sufferers May Be at Greater Risk of Ischemic Stroke

Tuesday, February 20, 2018—Stroke, a journal of the American Heart Association published an article by Alessandro Pezzine, Giorgio Busto, Marialuisa Zedde, et al., (Stroke. 2018:published online Feb 20)…

A Banner Year in Headache Medicine

Peter McAllister, MD

February 2018— By all indications, 2018 should prove to be a banner year for headache medicine. Many exciting changes are upon us, most notably the pending launch of the calcitonin gene-…

Reader Response to: Migraine and Other Neurologic Conditions in Retired NFL Players

Ira R. Casson, MD; and David C. Viano, Dr. med, PhD
Response From Author By Randolph W. Evans, MD

February 2018—We read with great interest Randolph Evans’ recent article in Practical Neurology.1 Dr. Evans stated that his cohort was a “biased, nonrandom sample seen as part o…

Calcitonin Gene-Related Peptide Monoclonal Antibodies

Simy K. Parikh, MD; and Stephen D. Silberstein, MD

February 2018—A new treatment for managing migraine in the clinic is on the horizon.

 
 

Contact Info

For advertising rates and opportunities:
Wendy Terry
Publisher
217-652-3859
wterry@bmctoday.com

About Practical Neurology

Launched in 2002, Practical Neurology is a publication uniquely dedicated to presenting current approaches to patient management, synthesis of emerging research and data, and analysis of industry news with a goal to facilitate practical application and improved clinical practice for all neurologists. Our straightforward articles give neurologists tools they can immediately put into practice.

 
  • BRYN MAWR COMMUNICATIONS III, LLC